REAL-TIME GLOBAL RESEARCH
Feedback from a KOL call on optometry
Research evidence excerpt
Feedback from a KOL call on optometry
Equity Research
European Medical Technology & Services
16 July 2026
EssilorLuxottica
Feedback from a KOL call on
optometry
KOL sees Stellest as a game changer. Prescribing for all ESLX.PA/EL FP OVERWEIGHT
POSITIVEeligible children and can see patients wearing them through EuropeanTechnologyMedical& Services
college, in conjunction with MiSight. Significant increase in Price Target EUR 300.00
coatings penetration as technology has improved. Sees Price (14-Jul-26) EUR 165.15 Potential Upside/Downside +81.7%
Source: Bloomberg, Barclays Researchlimited risk of cannibalisation of standard frames by
smart glasses
European Medical Technology &
Services
We were pleased to host a KOL call with Dr Alice Mann, optometrist and owner at Focal Point Hassan Al-Wakeel, CFA
Optical (09/1988-present) in Long Island, for a discussion on optometry trends, myopia +44 (0)20 7773 3898
management and smart glasses. We highlight three key takeaways with our notes below: 1) hassan.al-wakeel@barclays.com
Stellest. Our KOL expects it to be standard of care. Putting all kids who need glasses for the first Barclays, UK
time in Stellest. Can see patients wanting to use MiSight in their teens for sports and socialising, Jonathon Unwin
but expects they will have Stellest lenses, too, potentially throughout college. 2) Smart glasses. +44 (0)20 7773 0354
She sees this as a niche product, and sees limited cannibalisation risk of standard frames. jonathon.unwin@barclays.com
Warranty on the electronics means she cannot adjust the frames to the patient, which makes it Barclays, UK
harder to fit Rx lenses, particularly progressive lenses. All Rx lens fittings (into the frame) have to Marco Pires-Cox
The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.
Open report viewer